Regulatory affairs

Oct 1, 2016 by in GENERAL SURGERY Comments Off on Regulatory affairs

Chapter 20 Regulatory affairs I. Hägglöf, Å Holmgren Introduction This chapter introduces the reader to the role of the regulatory affairs (RA) department of a pharmaceutical company, outlining the process…

read more

High-throughput screening

Oct 1, 2016 by in GENERAL SURGERY Comments Off on High-throughput screening

Chapter 8 High-throughput screening D. Cronk Introduction: a historical and future perspective Systematic drug research began about 100 years ago, when chemistry had reached a degree of maturity that allowed…

read more

Biopharmaceuticals

Oct 1, 2016 by in GENERAL SURGERY Comments Off on Biopharmaceuticals

Chapter 12 Biopharmaceuticals H. LeVine Introduction The term ‘biopharmaceutical’ was originally coined to define therapeutic proteins produced by genetic engineering, rather than by extraction from normal biological sources. Its meaning…

read more

The role of pharmaceutical marketing

Oct 1, 2016 by in GENERAL SURGERY Comments Off on The role of pharmaceutical marketing

Chapter 21 The role of pharmaceutical marketing V M. Lawton Introduction This chapter puts pharmaceutical marketing into the context of the complete life-cycle of a medicine. It describes the old…

read more

Drug development: Introduction

Oct 1, 2016 by in GENERAL SURGERY Comments Off on Drug development: Introduction

Chapter 14 Drug development Introduction H P. Rang, R G. Hill Introduction Drug development comprises all the activities involved in transforming a compound from drug candidate (the end-product of the…

read more
Get Clinical Tree app for offline access